CN100509031C - Blood lipid-lowering medicine - Google Patents
Blood lipid-lowering medicine Download PDFInfo
- Publication number
- CN100509031C CN100509031C CNB200510005438XA CN200510005438A CN100509031C CN 100509031 C CN100509031 C CN 100509031C CN B200510005438X A CNB200510005438X A CN B200510005438XA CN 200510005438 A CN200510005438 A CN 200510005438A CN 100509031 C CN100509031 C CN 100509031C
- Authority
- CN
- China
- Prior art keywords
- extract
- blood lipid
- medicine
- blood
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Disclosed is a medicament for lowering blood fat and its preparing process, wherein the medicament comprises Chinese yam extract, root of kudzu vine extract, haw leaves extract, onion extract, Momordica grosvenori extract, stevioside and and magnesium stearate. The medicament can be made into dosage types of powder preparation, tablets or hard capsules.
Description
The present invention relates to a kind of blood lipid-lowering medicine and preparation method thereof, the constituent of this blood lipid-lowering medicine is made up of Rhizoma Dioscoreae extract, Radix Puerariae extract, Folium Crataegi extract, Bulbus Allii Cepae extract, Momordica-Glycosides, stevioside, magnesium stearate.With its preparation powder, tablet, hard capsule dosage form.Have the coronary artery dilator blood vessel, increase coronary artery and cerebral artery blood flow amount, prevent arteriosclerosis and thrombosis, fall effect for blood fat, blood glucose, blood pressure.Curative effect and health function to arteriosclerosis, thrombosis, hypertension, hyperlipidemia, coronary disease pain, angina pectoris, diabetes are obvious.
Knownly be used for arteriosclerosis, thrombosis, hypertension, hyperlipidemia, coronary disease pain, the treatment of diabetes medicine has hundreds of, all be with the synthetic product of chemical raw material, use continuously because of long-term, symptoms such as generation is felt sick, vomiting, headache, anorexia, erythra, perspiration, heating, concurrent hypoglycemia, low blood pressure.And improve the fibrinolytic activity effect and reduce the medicine of lipid effect, but have only antigenicity medicines such as urokinase, streptokinase, antidiabetic medicine has only insulin etc., and can not be oral, have only injection just effectively, certain untoward reaction and side effect are arranged.Its production cost height, technology, equipment complexity.
The objective of the invention is provides a kind of blood lipid-lowering medicine and preparation method thereof in order to solve the defective of above-mentioned existence.
For achieving the above object, the invention provides a kind of blood lipid-lowering medicine and preparation method thereof, this blood lipid-lowering medicine constituent by following percentage by weight is:
Rhizoma Dioscoreae extract 1-20%
Radix Puerariae extract 3-60%
Folium Crataegi extract 0.5-10%
Bulbus Allii Cepae extract 3-60%
Momordica-Glycosides 0.1-0.4%
Stevioside 0.01-0.1%
Magnesium stearate 0.1-4%
Preparation method of the present invention is described below:
1, the preparation of Rhizoma Dioscoreae extract: adopt the temperature more than 100 ℃ to decoct 90 minutes, reduce to room temperature, squeeze and filter, with filtrate concentrate, dry, to be crushed to 200 order fine powders standby.Decoct and use pure water, the material-water ratio example is 1:20.
2, the preparation of Radix Puerariae extract: adopt alcohol extraction twice, under 58-60 ℃ temperature, extracted 120 minutes at every turn, reduce to room temperature, squeeze and filter, merging filtrate, under 58-60 ℃ temperature, vacuum decompression concentrates, and is dry, to be crushed to 200 order fine powders standby.The feed liquid ratio is 1:20, the ethanol with 95%.
3, the preparation of Folium Crataegi extract: the preparation method that adopts Radix Puerariae extract.
4, the preparation of Bulbus Allii Cepae extract: adopt peeling to squeeze the juice, under 50 ℃ temperature, refine 60 minutes, solution of alcoholized is filtered, vacuum decompression concentrates under 58-60 ℃ temperature, and drying, to be crushed to 200 order fine powders standby.The feed liquid ratio is 1:10, makes solution of alcoholized with 95% ethanol.
5, the preparation of tablet: by above-mentioned constituent percentage by weight, weighing component, add 5% ethanol mix homogeneously, adopt the rotary tablet machine tabletting.60 ℃ temperature in the electric heating drying baker is dried to the moisture below 5%, reduces to room temperature, carries out irradiation after the packing.
6, the preparation of hard capsule: by above-mentioned constituent percentage by weight, weighing component, mix homogeneously adopts capsule charge mechanism capsule, packing back irradiation.
The blood lipid-lowering medicine that the present invention relates to is characterized by buff, has Herba Alii fistulosi fragrance and fruit to dredge sweet taste.
Pharmacological evaluation shows: the blood lipid-lowering medicine that the present invention relates to has the coronary artery dilator blood vessel, increases coronary artery and cerebral artery blood flow amount, prevents arteriosclerosis and thrombosis, the drug effect of blood fat reducing, blood glucose, blood pressure.Diseases such as arteriosclerosis, thrombotic disease, hypertension, hyperlipidemia, coronary heart disease, angina pectoris, diabetes there are obvious curative effects and health function.
Acute toxicity test shows: the blood lipid-lowering medicine that the present invention relates to, LD50 are the 20000mg/kg body weight, and safety evaluatio is actual non-toxic type, and is without any side effects.
Advantage of the present invention is to adopt the blood lipid-lowering medicine of natural plants preparation, has enlarged the scope of its application, can make full use of artificial growth and wild resource, and its resource is sufficient and guaranteed.
Another advantage of the present invention is to utilize natural plant resource, has reduced cost of material, preparation extract yield height, and production technology is simple, is fit to suitability for industrialized production.The most outstanding advantage of the present invention is to provide a kind of new medicine for the control cardiovascular and cerebrovascular disease.
Embodiment:
Get Rhizoma Dioscoreae extract 80g, Radix Puerariae extract 240g, Folium Crataegi extract 400g, Bulbus Allii Cepae extract 6000g, Momordica-Glycosides 0.2g, stevioside 0.1g, stearic enzyme magnesium 400g adds edible ethanol 100ml, mix homogeneously.Employing is tabletting in rotary tablet machine, and 8000 in preparation tablet is the 1.25g/ sheet.Carry out drying and be placed in the electric heating drying baker 60 ℃, and ethanol is volatilized fully, be finished product, standby with PP plastic bottle splendid attire.Give 40 people's lab-gowns with 30 days, 3 times for each person every day, each 2.40 people are overt diabetes companion hyperlipemia, and inactive other medicines 30 days.Through the repeated detection fasting plasma lipid, T-CHOL (TO) 〉=6.30mmol/L, triglyceride (TO) 〉=1.98mmol/L, high density lipoprotein (HDL)≤1.10mmol/L.Experimentize and take front and back self contrast, carry out curative effect more relatively.Lab-gown was with 30 days, and testing crew TC, TO significantly descend, and HDL obviously raises (P＜0.001), and the TC rate of descent is 25.7-46.5%.Individual curative effect difference, there have 3 people TO to descend to be apparent in view, and the TO rate of descent is respectively 31.5%, 49%, 58.1% after taking medicine 30 days.Wherein 21 people are the hyperpietic, and high TO patient carries out the medicine examination, obtains good result, and the blood pressure lowering rate is 82.5%; The blood pressure drops amplitude, systolic pressure decline 3.10kpa, diastolic pressure on average reduces 2.7kpa, and its hypotensive effect is remarkable, and with blood vessel dilating, it is relevant to reduce Peripheral resistance.Diabetics to the examination clothes is also obtained good lipid-lowering effect, the TO 1.15mmol/L that on average descends has significantly the effect of TC and rising HDL down, and TC on average reduces 3.07mmol/L, the HDL 0.84mmol/L that on average raises, its curative effect is higher than vitamin E (P＜0.05-0.01).Clinical trial is the result show: the blood lipid-lowering medicine that the present invention relates to is tangible natural blood lipid-lowering medicine of a kind of curative effect and health product.
The above embodiment of the present invention only is to be exemplifying that explanation is clearly done, and is not qualification to embodiment of the present invention, to the fabricating technology scheme in affiliated field.Obviously can make other multi-form variation on the basis of the above description, the product of preparation difformity and dosage form need not also can't give all embodiments exhaustive here.And the product of these variations and different types thereof still is among protection scope of the present invention.
Claims (2)
1, a kind of blood lipid-lowering medicine, it is characterized in that forming: Rhizoma Dioscoreae pure water extract 1-20%, Radix Puerariae ethanol extraction 3-60%, Folium Crataegi ethanol extraction 0.5-10%, Bulbus Allii Cepae ethanol extraction 3-60%, Momordica-Glycosides 0.1-0.4%, stevioside 0.01-0.1%, magnesium stearate 0.1-4% by following components in weight percentage.
2, according to claim 1, it is characterized in that, after being mixed, each component makes tablet or hard capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510005438XA CN100509031C (en) | 2005-01-05 | 2005-01-05 | Blood lipid-lowering medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510005438XA CN100509031C (en) | 2005-01-05 | 2005-01-05 | Blood lipid-lowering medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1799601A CN1799601A (en) | 2006-07-12 |
| CN100509031C true CN100509031C (en) | 2009-07-08 |
Family
ID=36809960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510005438XA Expired - Fee Related CN100509031C (en) | 2005-01-05 | 2005-01-05 | Blood lipid-lowering medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100509031C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2207420A4 (en) * | 2007-10-10 | 2011-01-12 | Global Organics Llc | Anti-glycation methods and compositions |
| CN103566150B (en) * | 2013-10-10 | 2016-01-06 | 北京昊源康科技有限公司 | A kind of compositions and application thereof with the integration of edible and medicinal herbs food of effect for reducing blood fat |
| CN105249321A (en) * | 2015-09-01 | 2016-01-20 | 上海医药工业研究院 | Composition and preparation method and application thereof |
| CN115813871A (en) * | 2022-12-23 | 2023-03-21 | 宝利康生物科技(天津)有限公司 | Blood pressure reducing tablet candy and application method thereof |
-
2005
- 2005-01-05 CN CNB200510005438XA patent/CN100509031C/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 降血脂抗血栓降血压的常用中药药理介绍. 万，春，彭翠波.现代中西医结合杂志，第13卷第21期. 2004 |
| 降血脂抗血栓降血压的常用中药药理介绍. 万，春，彭翠波.现代中西医结合杂志，第13卷第21期. 2004 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1799601A (en) | 2006-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102362881A (en) | Method for preparing ginkgo and American ginseng preparation | |
| CN102423352B (en) | Preparation method of Chinese medicinal granules for treating cardio-cerebrovascular diseases | |
| CN101693062B (en) | Health-care product for reducing pressure and sugar and eliminating fat | |
| CN102293868A (en) | Application of total flavonoids of lilac daphne root to preparation of medicament for reducing blood sugar | |
| CN101129790A (en) | Compound hippophae rhamnoides lozenge method of producing the same | |
| CN100509031C (en) | Blood lipid-lowering medicine | |
| CN101816414B (en) | Application of sunflower leaves for preparing foods and health-care foods for reducing blood pressure in auxiliary way | |
| CN106723029A (en) | A kind of health food and its preparation technology with auxiliary hyperglycemic function | |
| CN106072635A (en) | A kind of preparation method of Radix Ginseng buccal tablet | |
| CN102727548A (en) | New technology and method for extracting ginseng stem and leaf total saponin | |
| CN101804089A (en) | Use of total flavonoids from radix Daphne genkwa in preparing weight-losing hypolipemic drugs | |
| CN112914008A (en) | Health-care solid beverage for constitution of qi depression and preparation method thereof | |
| CN1330353C (en) | Chinese traditional medicine for adjusting contents of blood sugar and blood fat, and preparation method | |
| CN109717426A (en) | A kind of hypoglycemia healthcare food and preparation method thereof | |
| CN104336287B (en) | Syringa pubescens sugar-free health-care candy with blood pressure lowering effect and preparation method thereof | |
| CN1853670B (en) | Coronary heart Danshen root micropellets and preparation thereof | |
| CN102068520A (en) | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN1977944A (en) | Red ginseng and lilyturf root soft capsule and its preparing method | |
| CN1123097A (en) | "Jiangtanghu" and its production technology | |
| CN101518554A (en) | Oral medicinal preparation of hairy holly root total aglycon, preparation method and application thereof | |
| CN102139057B (en) | Healthcare tea capable of lowering glucose | |
| CN102715502B (en) | Preparation method of health food with function of anti-diabetes | |
| CN101623325B (en) | Ziziphora clinopodioides Lam. total flavonoid extract and production method thereof and application thereof in cardiovascular drug | |
| CN105055979A (en) | Traditional Chinese medicine compounded composition and lozenge for preventing and curing diabetes and preparation method thereof | |
| CN109939186A (en) | A kind of preparation method of Chinese materia medica preparation and its Chinese patent drug for treating hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Cao Zhengan Document name: Notice of publication of application for patent for invention |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhuhai Enzhaoer Biological Technology Co., Ltd. Document name: Notification of the application for patent for invention to go through the substantive examination procedure Addressee: Zhuhai Enzhaoer Biological Technology Co., Ltd. Document name: Notice of conformity |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20090220 Address after: Jiangsu Province, Wuxi new area, industrial park five B14-1 plots (located at the intersection of Sun Anlu and Shannon Road) post encoding: 214000 Applicant after: Jiangsu AnJi Biotechology Co., Ltd. Address before: Guangdong province Zhuhai city Xiangzhou District Jida Bailian Road No. 49 Building 9 post encoding: 519015 Applicant before: Zhuhai Enzhaoer Biological Technology Co., Ltd. |
|
| ASS | Succession or assignment of patent right |
Owner name: JIANGSU ANJIER BIOLOGY TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHUHAI ENSHAOER BIOLOGICAL SCIENCE AND TECHNOLOGY LTD. Effective date: 20090220 |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Jiangsu AnJi Biotechology Co., Ltd. Document name: Review of business letter |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090708 Termination date: 20100205 |